Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image - PubMed (original) (raw)
. 1984 May;44(5):2115-21.
- PMID: 6324996
Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image
K Iwai et al. Cancer Res. 1984 May.
Abstract
Highly malignant rabbit tumor (VX-2) was implanted at the periphery of the liver in 63 rabbits. Selective delivery of the anticancer agent copoly(styrenemaleic acid) conjugated to neocarzinostatin (SMANCS), which was dissolved in an oil contrast medium (Lipiodol), was performed by injection via the proper hepatic artery. The anticancer effect was also evaluated by various parameters. By using low-kVp X-ray examination of the resected rabbit liver, Lipiodol was found to distribute throughout the entire liver arterial lumina and was retained there for about 24 hr, but disappeared from the normal liver arterial lumina gradually. However, Lipiodol was retained in the tumor tissue and vessels for at least 7 days, whereas it was undetectable in any other organs. A radioactive analogue of Lipiodol, a chloroiodinated fatty acid, was prepared by using [14C]linoleic acid. This analogue was used in the study of the distribution by low-kVp X-ray examination, Sudan III staining, and autoradiography. Lipiodol remained in the tumor vessels as well as the tumor cells. The use of the radioisotope yielded a quantitative profile of Lipiodol accumulation in tumor tissues; approximately 1000 times more at 15 min and 100 times more at 3 days after the injection than that of most other organs or plasma. Its major excretion route appeared to be through the bile and then the feces. The biological activity of SMANCS was also determined and was found to be significant in both tumor and liver even 7 days after injection. No activity was found in any other organ or tissue. The relatively high biological activity of SMANCS in the nontumorous liver adjacent to the tumor may be the result of continuous drug release from SMANCS-Lipiodol in the tumor tissue. By histological examination, massive tumor necrosis and infiltration of the inflammatory cells were found in the rabbits treated with SMANCS-Lipiodol. In the rabbits treated with Lipiodol alone, necrosis of the tumor was only minimal, and no infiltration of inflammatory cells was observed. Survival periods of the treated rabbits (n = 14) were significantly longer than those of controls (n = 10); 23.1 +/- 5.5 (S.D.) days versus 16.1 +/- 2.9 days (p less than 0.005), respectively, even though only one injection was used for this highly malignant tumor. Mean tumor size for both groups at laparotomy was 163.3 +/- 83.0 sq mm and 160.5 +/- 76.5 sq mm, respectively (not significant).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
Yamasaki K, Konno T, Miyauchi Y, Maeda H. Yamasaki K, et al. Cancer Res. 1987 Feb 1;47(3):852-5. Cancer Res. 1987. PMID: 3026619 - [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
Yamasaki K, Konno T, Miyauchi Y, Maeda H. Yamasaki K, et al. Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1224-8. Gan To Kagaku Ryoho. 1987. PMID: 3034169 Japanese. - Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
Noda S, Konno S, Tanaka J, Yamada M, Yoshitake N. Noda S, et al. Anticancer Res. 1990 May-Jun;10(3):709-15. Anticancer Res. 1990. PMID: 2164351 - [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T, Maeda H. Konno T, et al. Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):1043-50. Gan To Kagaku Ryoho. 1988. PMID: 2839112 Review. Japanese.
Cited by
- A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors.
Nomani A, Yousefi S, Sargsyan D, Hatefi A. Nomani A, et al. J Control Release. 2024 Apr;368:728-739. doi: 10.1016/j.jconrel.2024.03.019. Epub 2024 Mar 19. J Control Release. 2024. PMID: 38493951 - Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.
Dieudonné A, Becker S, Soares M, Hollenbeck C, De Goltstein MC, Vera P, Santus R. Dieudonné A, et al. EJNMMI Res. 2023 Nov 23;13(1):101. doi: 10.1186/s13550-023-01051-9. EJNMMI Res. 2023. PMID: 37995042 Free PMC article. - Nanomedicine in cancer therapy.
Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Fan D, et al. Signal Transduct Target Ther. 2023 Aug 7;8(1):293. doi: 10.1038/s41392-023-01536-y. Signal Transduct Target Ther. 2023. PMID: 37544972 Free PMC article. Review. - Polymer nanocarriers for targeted local delivery of agents in treating brain tumors.
Josowitz AD, Bindra RS, Saltzman WM. Josowitz AD, et al. Nanotechnology. 2022 Dec 2;34(7):10.1088/1361-6528/ac9683. doi: 10.1088/1361-6528/ac9683. Nanotechnology. 2022. PMID: 36179653 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources